- Can AI do scientific research?; The 'magic bullet' search has faded in immunotherapy; and moreWelcome back to Endpoints Weekly! We’ve got a team of reporters on the ground in Chicago this weekend for ASCO, including my fellow Weekly co-author Max Gelman. If you haven’t already, check out Ma…Endpoints · 1mo ago↗ source
- Next FDA user fee deal is under review at the White HouseThe White House is examining a deal recently reached by the FDA and the biopharma industry that sets the prescription drug user fees that the sector will pay the agency from 2028 through 2032, sour…Endpoints · 1mo ago↗ source
- Post-Hoc: Lilly gets more secretive and hides Phase 1 pipelineEli Lilly is getting more opaque as it gets bigger. Earlier this year, the drugmaker stopped disclosing its early-stage pipeline work. Its Phase 1 projects vanished from the company’s earnings pr…